J.P. MORGAN SPARK Trademark

Trademark Overview


On Friday, December 15, 2023, a trademark application was filed for J.P. MORGAN SPARK with the United States Patent and Trademark Office. The USPTO has given the J.P. MORGAN SPARK trademark a serial number of 98316942. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Tuesday, July 23, 2024. This trademark is owned by JPMorgan Chase Bank, N.A.. The J.P. MORGAN SPARK trademark is filed in the Insurance & Financial Services category with the following description:

Investment management
j.p. morgan spark

General Information


Serial Number98316942
Word MarkJ.P. MORGAN SPARK
Filing DateFriday, December 15, 2023
Status641 - NON-FINAL ACTION - MAILED
Status DateTuesday, July 23, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesInvestment management

Classification Information


International Class036 - Insurance; financial affairs; monetary affairs; real estate affairs.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateFriday, December 15, 2023
Primary Code036
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameJPMorgan Chase Bank, N.A.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressColumbus, OH 43240

Trademark Events


Event DateEvent Description
Friday, December 15, 2023NEW APPLICATION ENTERED
Wednesday, March 27, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, July 23, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, July 23, 2024NON-FINAL ACTION E-MAILED
Monday, July 15, 2024ASSIGNED TO EXAMINER
Tuesday, July 23, 2024NON-FINAL ACTION WRITTEN
Wednesday, October 2, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Wednesday, October 2, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED

Related Keywords


spark morgan management investment